← FDA Drug Approvals (Drugs@FDA)
RIMEGEPANT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX CORP · Approved 2025-12-31
Drug application
- FDA Application #
ANDA219399- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIMEGEPANT
- Generic name
- Rimegepant
- Active ingredients
- RIMEGEPANT
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- APOTEX CORP
- First approval
- 2025-12-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown